The initial public offerings for two pharmaceutical companies are set to compete for investor attention when they float next week.
UBS Warburg and CIBC World Markets are leading the offering for Aderis Pharmaceuticals, and CIBC will also lead the Dov Pharmaceutical float along with Lehman Brothers.